Clínica Baviera, S.A.

MSE:CBAV.MC

35.3 (EUR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32017 Q22017 Q1
Operating Activities:
Net Income 15.71716.77613.1257.40413.37915.7457.8996.36611.49314.9229.1027.58411.27910.9349.0076.6341.4773.0685.4432.3044.9015.1414.8331.653.223.49
Depreciation & Amortization 5.0544.5714.6224.3144.1253.923.8573.8683.6953.5773.5953.5813.4383.483.4183.3763.3553.3963.5053.3013.3243.0971.2921.2321.2751.33
Deferred Income Tax 00000000000000000000000000
Stock Based Compensation 00000000000000000000000000
Change In Working Capital 0.726-0.7253.0821.71-0.576-2.4596.047-0.2590.575-1.45.299-1.4982.19-2.1532.9191.036-0.078-1.4780.2750.072-1.606-0.861.1770.999-0.067-1.194
Accounts Receivables 00000000000000000000000000
Change In Inventory 00000000000000000000000000
Change In Accounts Payables 00000000000000000000000000
Other Working Capital 00000000000000000000000000
Other Non Cash Items 013.171-4.935-1.1210-11.605-2.3477.488-11.933-0.471-5.5528.479-11.082-1.82-3.8660.105-0.688-0.226-1.99-0.278-1.3530.125-2.528-0.927-0.7140.028
Operating Cash Flow 18.01220.28915.89312.30712.69216.9215.45617.4633.8316.62812.44518.1465.82510.44111.47911.1514.0664.767.2345.3995.2667.5034.7752.9543.7143.654
Investing Activities:
Investments In Property Plant And Equipment -6.405-6.785-8.513-5.74-5.221-3.205-6.936-2.434-2.801-1.86-3.948-2.105-3.178-1.344-4.205-1.733-1.052-0.829-2.692-1.705-2.66-2.134-3.196-2.702-1.037-1.738
Acquisitions Net 000000-1.405000-0.0020000000-0.01-0.10.536-1.3320000
Purchases Of Investments 000000-24.516000-6.457000-13.59200000000000
Sales Maturities Of Investments 00000025.9210000000000000000000
Other Investing Activites -10.744-0.015-21.86910.825001.5475.017-5.085-0.007-6.5360.987-0.9950.038-13.5926.022-6.01-0.0033.4451.008-0.824-0.210.583-0.402-1.303-0.163
Investing Cash Flow -17.338-6.8-30.3825.085-15.811-3.205-5.3892.583-7.886-1.867-10.484-1.118-4.173-1.306-17.7974.289-7.062-0.8320.743-0.797-2.948-3.676-2.613-3.104-2.34-1.901
Financing Activities:
Debt Repayment 0-0.501-0.502-0.328-0.676-0.498-0.501-3.365-1.036-1.151-1.314-1.572-1.365-1.524-1.543-1.419-1.787-1.157-1.42400-1.359-3.5710-1.258-1.157
Common Stock Issued 0000000.597-0.2440.24400.503-0.1490.14900.19600000000000
Common Stock Repurchased 000000-0.6170.26-0.260-0.4910.167-0.1670-0.19100000000000
Dividends Paid 00-0.034-0.16800-8.151-0.117-8.920-8.216-0.03-9.10200000-0.116000-0000
Other Financing Activities -5.548-0.1130-2.508-4.1550.005-2.333-11.09-1.886-1.812-1.869-11.068-1.936-1.932-1.214-2.083-1.8167.865-4.504-7.815-2.016-1.4791.21-0.227-0.7261.065
Financing Cash Flow -12.585-2.854-2.577-3.004-16.241-2.544-11.005-14.556-2.922-2.963-11.399-12.64-3.301-3.456-2.756-3.502-3.6036.708-6.045-7.815-2.016-2.838-2.361-0.227-1.984-0.092
Other Information:
Effect Of Forex Changes On Cash 000000-4.451-14.62200000000-2.5670000000-7.7990
Net Change In Cash -11.91110.635-17.06514.388-19.360-5.389-9.132-6.9781.997-9.439-10.464-1.649-5.143-9.07511.938-9.16610.6361.932-3.2130.3020.989-0.199-0.377-8.4091.661
Cash At End Of Period -11.91110.635-17.06514.388-19.3619.173-5.3895.49-6.97811.798-9.4394.388-1.6495.679-9.07511.9387.95817.1241.932-3.2130.3020.989-0.199-0.3775.07713.486